Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease | Synapse
March 28, 2026Open Access
Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
Key Points
To evaluate the effectiveness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease.
Correlational analysis of fecal calprotectin levels with disease activity scores and endoscopic findings.
Comparison of fecal calprotectin with C-reactive protein (CRP) for detecting endoscopic activity.
Fecal calprotectin levels showed strong correlation with disease activity index and endoscopic inflammation.
Fecal calprotectin was more effective than CRP in identifying endoscopic activity.
Abstract
FC levels correlated with DAIBD scores and endoscopic inflammation in intestinal BD. FC outperformed CRP in detecting endoscopic activity, supporting its use in disease management.